ANL NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Adlai Nortye Ltd. American Depositary Shares · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 13.28 USD
2.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 28.8% above the Trend Line and sits at 75.8% of its 52-week range. The latest completed week returned 2.2%, after a 34.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 56/100.

Setup score 63 out of 100
Latest Close 13.28 USD 7 Aug 2026
1W Return 2.2% latest completed week
4W Return 34.5% short-term follow-through
12W Return -1.7% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 29-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.2% Latest completed week; four-week move 34.5%. Indicator stack 76/42 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 56/100 49 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 28.8% above the Trend Line and sits at 75.8% of its 52-week range. The latest completed week returned 2.2%, after a 34.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5012-week average 0.74

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.50Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 34.5% over four weeks, -1.7% over 12 weeks, and 751.3% over one year. The current trend has remained active for 29 consecutive weeks.

Performance by holding period

1W2.2%
4W34.5%
12W-1.7%
26W32.7%
52W751.3%
Active trend streak29 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.55Latest activity-pressure read.
Pressure change28.1%Four-week change in activity pressure.
Leadership82.19Latest relative-leadership reading.
RS change55.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 70% Model confidence 66%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength75/100Blend of value, momentum, and quality. Underlying universe rank 26; rank 1 is best.
Value62/100Relative valuation strength. Underlying universe rank 39; rank 1 is best.
Quality60/100Profitability and accounting quality. Underlying universe rank 41; rank 1 is best.
Momentum63/100Medium-term price momentum. Underlying universe rank 38; rank 1 is best.
Growth62/100Revenue and earnings growth. Underlying universe rank 39; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
167.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-4.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
100.0%
Gross profit retained from each unit of revenue.
Operating margin
-680.8%
Operating profit retained from revenue.
Free-cash-flow margin
-667.0%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 49 relevant articles.

17 positive · 28 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-23.0%Distance below the 52-week high.
13-week volatility8.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+43.5%Week of 17 Apr.
Worst week-20.8%Week of 27 Feb.
Latest week+2.2%Week of 7 Aug.

Shape of recent returns

Strong gains10
Modest gains4
Flat weeks0
Modest losses2
Sharp losses10
Recent vol8.1%13-week weekly-return volatility.
Base vol44.2%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew21.0% / -10.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape59/100

Trend, activity pressure, participation, and risk combine to a 59/100 tape read.

 Indicator analysis65/100

Latest 12-week confirmation: trend 12/12, activity pressure 2/12, relative leadership 12/12.

Activity pressure 0.50; No reversal markers Factors64/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 46; Small Cap Core rank 46 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 49 relevant articles.

Adlai Nortye: AN9025 Still Needs Human Validation (NASDAQ:ANL) Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202613.28 USD2.2%10.31 USD5.61 USD-0.5582.191.1MOn
31 Jul 202613.00 USD4.0%9.92 USD5.55 USD-0.6793.20693.6KOn
24 Jul 202612.50 USD8.4%9.54 USD5.50 USD-0.6992.961.2MOn
17 Jul 202611.53 USD16.8%9.18 USD5.46 USD-0.7280.931.5MOn
10 Jul 20269.87 USD4.0%8.84 USD5.41 USD-0.7752.891.2MOn
3 Jul 20269.49 USD-5.1%8.56 USD5.38 USD-0.7853.211.0MOn
26 Jun 202610.00 USD-1.0%8.28 USD5.36 USD-0.7666.75795.6KOn
19 Jun 202610.10 USD-2.1%8.00 USD5.32 USD-0.6265.07424.8KOn
12 Jun 202610.32 USD3.7%7.70 USD5.29 USD-0.3977.65571.5KOn
5 Jun 20269.95 USD-16.7%7.41 USD5.25 USD-0.0780.06698.4KOn
29 May 202611.94 USD0.2%7.13 USD5.22 USD0.24112.05327.0KOn
22 May 202611.92 USD-11.8%6.78 USD5.17 USD0.58125.011.1MOn
15 May 202613.51 USD1.7%6.44 USD5.12 USD0.80167.14576.2KOn
8 May 202613.28 USD-14.3%6.04 USD5.06 USD0.96173.151.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.